IL33 and neoplasm: Most studies attribute a protumorigenic role to the IL-33/ST2 axis in human, murine and in vitro models, with increased levels of IL-33 and ST2 transcripts in tumor vs. healthy tissue from CRC patients (34, 36, 39).